|
 | Up a level |
Jeyasankar, S and Kalapala, YC and Sharma, PR and Agarwal, R (2024) Antibacterial efficacy of mycobacteriophages against virulent Mycobacterium tuberculosis. In: BMC Microbiology, 24 (1).
Gupta, VK and Vaishnavi, VV and Arrieta-Ortiz, ML and Abhirami, PS and Jyothsna, KM and Jeyasankar, S and Raghunathan, V and Baliga, NS and Agarwal, R (2024) 3D Hydrogel Culture System Recapitulates Key Tuberculosis Phenotypes and Demonstrates Pyrazinamide Efficacy. In: Advanced Healthcare Materials .
Narayan, R and Sharma, M and Yadav, R and Biji, A and Khatun, O and Kaur, S and Kanojia, A and Joy, CM and Rajmani, R and Sharma, PR and Jeyasankar, S and Rani, P and Shandil, RK and Narayanan, S and Rao, DC and Satchidanandam, V and Das, S and Agarwal, R and Tripathi, S (2023) Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo. In: Cell Reports Medicine, 4 (8).
George, E and Goswami, A and Lodhiya, T and Padwal, P and Iyer, S and Gauttam, I and Sethi, L and Jeyasankar, S and Sharma, PR and Dravid, AA and Mukherjee, R and Agarwal, R (2022) Immunomodulatory effect of mycobacterial outer membrane vesicles coated nanoparticles. In: Biomaterials Advances, 139 .
Sharma, PR and Dravid, AA and Kalapala, YC and Gupta, VK and Jeyasankar, S and Goswami, A and Agarwal, R (2021) Cationic inhalable particles for enhanced drug delivery to M. tuberculosis infected macrophages. In: Materials Science and Engineering C .
